Visual Hallucinations After Duloxetine Use

References (10)

1. Yazici KU, Yazici IP. Visual hallucination induced by duloxetine use: a male case diagnosed with generalized anxiety disorder. Psychiatry Clin Psychopharmacol. 2018;28(3):346–348. CrossRef
2. Rolma G, Jelcic N, Gnoato F, et al. Combined duloxetine and benzodiazepine-induced visual hallucinations in prodromal dementia with Lewy bodies. Gen Hosp Psychiatry. 2013;35(6):678.e7–678.e9. PubMed CrossRef
3. Gündüz N, Eren F, Turan H, et al. Visual and tactil hallucinations after duloxetine use: a case report. Alpha Psychiatry. 2018;19(1):103–105.
4. Tomita T, Yasui-Furukori N, Kaneko S. Visual hallucinations during duloxetine treatment in a patient with major depressive disorder. Clin Neuropharmacol. 2013;36(5):175–176. PubMed CrossRef
5. Mancini M, Perna G, Rossi A, et al. Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature. Expert Opin Pharmacother. 2010;11(7):1167–1181. PubMed CrossRef
6. Stahl SM, Grady MM, Moret C, et al. SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectr. 2005;10(9):732–747. PubMed CrossRef
7. Preskorn SH, Greenblatt DJ, Flockhart D, et al. Comparison of duloxetine, escitalopram, and sertraline effects on cytochrome P450 2D6 function in healthy volunteers. J Clin Psychopharmacol. 2007;27(1):28–34. PubMed CrossRef
8. Morón JA, Brockington A, Wise RA, et al. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J Neurosci. 2002;22(2):389–395. PubMed CrossRef
9. Stahl SM. Neurotransmission of cognition, part 3: mechanism of action of selective NRIs: both dopamine and norepinephrine increase in prefrontal cortex. J Clin Psychiatry. 2003;64(3):230–231. PubMed
10. Cancelli I, Marcon G, Balestrieri M. Factors associated with complex visual hallucinations during antidepressant treatment. Hum Psychopharmacol. 2004;19(8):577–584. PubMed CrossRef